DAVID SOLA-DEL VALLE, MD
Glaucoma Specialist (Ophthalmology) Physician in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: DAVID SOLA-DEL VALLE, MD filed 5,935 Medicare Part D claims in 2023 across BOSTON, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
DAVID SOLA-DEL VALLE, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
DAVID SOLA-DEL VALLE, MD at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Massachusetts
How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Massachusetts providers
Glaucoma Specialist (Ophthalmology) Physician share within Massachusetts
Glaucoma Specialist (Ophthalmology) Physician is one of the more visible NUCC categories in Massachusetts
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Glaucoma Specialist (Ophthalmology) Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Glaucoma Specialist (Ophthalmology) Physician ABMS/AOA estimate
Est. board-certified rate (Glaucoma Specialist (Ophthalmology) Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Glaucoma Specialist (Ophthalmology) Physician US NPIs
Specialty board-certified rate — Glaucoma Specialist (Ophthalmology) Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
DAVID SOLA-DEL VALLE, MD is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1235423260. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
DAVID SOLA-DEL VALLE, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 319 A ST UNIT 208, BOSTON, MA, 02210, with a listed phone of (787) 340-3379. NPI 1235423260 was issued on 06/07/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SOLA-DEL VALLE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,935 prescription claims written by this provider, covering 746 Medicare beneficiaries and totaling roughly $1.4 million in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1235423260 |
|---|---|
| Specialty | Glaucoma Specialist (Ophthalmology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/07/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm DAVID SOLA-DEL VALLE, MD's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DAVID SOLA-DEL VALLE, MD. Source: openpaymentsdata.cms.gov.
Total received
$27.0K
Largest payer
Thea Pharma Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Massachusetts BORIM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to DAVID SOLA-DEL VALLE, MD. To verify DAVID SOLA-DEL VALLE, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 12,439
- Total Day Supply
- 361,444
- Generic Drug Cost
- $291K
- Antibiotic Claims
- 22
Patient Demographics
- Average Patient Age
- 75.1 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 59, 65-74: 293, 75-84: 289, 85+: 105
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Latanoprost | 902 |
| Brimonidine Tartrate | 650 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 530 |
| Rhopressa Netarsudil Mesylate | 485 |
| Prednisolone Acetate | 369 |
| Vyzulta Latanoprostene Bunod | 282 |
| Timolol Maleate | 280 |
| Dorzolamide Hcl | 205 |
| Alphagan P Brimonidine Tartrate | 174 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Glaucoma Specialist (Ophthalmology) Physician Overview
How DAVID SOLA-DEL VALLE, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.
DAVID SOLA-DEL VALLE, MD's 5,935 claims are above the specialty average of 2,962.
Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as SOLA-DEL VALLE.
Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is DAVID SOLA-DEL VALLE, MD's specialty? ▼
How much does DAVID SOLA-DEL VALLE, MD prescribe under Medicare Part D? ▼
Where is DAVID SOLA-DEL VALLE, MD located? ▼
What is DAVID SOLA-DEL VALLE, MD's NPI number? ▼
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US? ▼
What drugs does DAVID SOLA-DEL VALLE, MD prescribe most often? ▼
Does DAVID SOLA-DEL VALLE, MD accept Medicare? ▼
How can I verify DAVID SOLA-DEL VALLE, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology